This article first appeared on GuruFocus.

State Street Health Care Select Sector SPDR ETF (XLV) posted a one-day stretch of selling on Monday, with ETF activity showing $320.2 million sold and nothing bought. The fund, with $50.54 billion in assets, decreased all 60 of its positions and increased none, for net selling of $320.2 million.

What did XLV sell on Monday?

Its largest sells by dollar value were LLY ($53.1 million), JNJ ($31.9 million) and ABBV ($24.4 million).

The largest sale was Eli Lilly + Co (LLY), where 37,604 shares were cut for $53.1 million, still 16.58% of assets. Johnson + Johnson (JNJ) shed 113,220 shares worth $31.9 million, AbbVie Inc (ABBV) 83,028 shares for $24.4 million, Merck + Co. Inc. (MRK) 115,906 shares for $17.2 million and UnitedHealth Group Inc (UNH) 42,160 shares for $16.8 million. None of the moves was a new position or a full exit.

How does XLV invest?

The fund is an Equity Sector Healthcare fund holding 60 stocks, with 60.7% of assets in its 10 largest holdings. Healthcare accounts for 100.0% of the stocks that could be classified, and the mix is 99.9% large-cap and 0.1% mid-cap. It charges 0.08% and its top holdings are Eli Lilly + Co at 16.58%, Johnson + Johnson at 9.98%, AbbVie Inc at 7.61%, Merck + Co. Inc. at 5.39% and UnitedHealth Group Inc at 5.24%. It has a GF Score of 85, a P/E of 28.58, a P/B of 4.25, a dividend yield of 1.36% and a year-to-date return of 23.53%.

State Street Health Care Select Sector SPDR ETF (XLV) at a glance

See the full State Street Health Care Select Sector SPDR ETF profile, or compare it with similar funds in the ETF Screener. Its biggest sell this time, LLY, has its own GF Value page and stock summary.

What should investors watch next for XLV?

Watch whether the next holdings update shows further trims across the 60-stock lineup or a return to buying, and whether Eli Lilly’s 16.58% weight shifts.